Multiphasic CT-based multimodal deep learning model for predicting early hepatocellular carcinoma recurrence following liver transplantation.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
147 patients with HCC who underwent liver transplantation at Tianjin First Central Hospital between June 2014 and September 2022.
I · Intervention 중재 / 시술
liver transplantation at Tianjin First Central Hospital between June 2014 and September 2022
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
SHAP analysis identified key predictive features contributing to model performance. [CONCLUSION] The MD DL model integrating multiphasic CT and clinical parameters demonstrated high predictive accuracy for early recurrence of HCC after liver transplantation, with diagnostic performance exceeding that of conventional models.
[OBJECTIVE] This study aimed to develop a multimodal deep learning (MD DL) model integrating multiphasic computed tomography (CT) with clinical and laboratory parameters to predict early recurrence of
APA
Wang Z, Li XR, et al. (2026). Multiphasic CT-based multimodal deep learning model for predicting early hepatocellular carcinoma recurrence following liver transplantation.. Frontiers in oncology, 16, 1767885. https://doi.org/10.3389/fonc.2026.1767885
MLA
Wang Z, et al.. "Multiphasic CT-based multimodal deep learning model for predicting early hepatocellular carcinoma recurrence following liver transplantation.." Frontiers in oncology, vol. 16, 2026, pp. 1767885.
PMID
41971433 ↗
Abstract 한글 요약
[OBJECTIVE] This study aimed to develop a multimodal deep learning (MD DL) model integrating multiphasic computed tomography (CT) with clinical and laboratory parameters to predict early recurrence of hepatocellular carcinoma (HCC) following liver transplantation.
[METHODS] A retrospective analysis was conducted on 147 patients with HCC who underwent liver transplantation at Tianjin First Central Hospital between June 2014 and September 2022. Patients were categorized into recurrence ( = 40) and non-recurrence ( = 107) groups. Independent risk factors for early recurrence were identified to construct a clinical-imaging model. Deep learning models were developed using both single-phase and multiphasic CT images. High-dimensional imaging features were combined with clinicoradiological parameters to establish the MD DL model. Model performance was evaluated using receiver operating characteristic curves and the DeLong test, while interpretability was assessed through SHapley Additive explanation (SHAP) analysis.
[RESULTS] Independent risk factors for early recurrence included platelet count, alpha-fetoprotein levels > 400 ng/mL, ascites, arterial peritumoral enhancement, and portal vein tumor thrombus. The MD DL model achieved area under the curve values of 0.972, 0.885, and 0.985 in the training, validation, and test sets, respectively. These values indicated significantly superior predictive performance compared with other models (all < 0.05). SHAP analysis identified key predictive features contributing to model performance.
[CONCLUSION] The MD DL model integrating multiphasic CT and clinical parameters demonstrated high predictive accuracy for early recurrence of HCC after liver transplantation, with diagnostic performance exceeding that of conventional models.
[METHODS] A retrospective analysis was conducted on 147 patients with HCC who underwent liver transplantation at Tianjin First Central Hospital between June 2014 and September 2022. Patients were categorized into recurrence ( = 40) and non-recurrence ( = 107) groups. Independent risk factors for early recurrence were identified to construct a clinical-imaging model. Deep learning models were developed using both single-phase and multiphasic CT images. High-dimensional imaging features were combined with clinicoradiological parameters to establish the MD DL model. Model performance was evaluated using receiver operating characteristic curves and the DeLong test, while interpretability was assessed through SHapley Additive explanation (SHAP) analysis.
[RESULTS] Independent risk factors for early recurrence included platelet count, alpha-fetoprotein levels > 400 ng/mL, ascites, arterial peritumoral enhancement, and portal vein tumor thrombus. The MD DL model achieved area under the curve values of 0.972, 0.885, and 0.985 in the training, validation, and test sets, respectively. These values indicated significantly superior predictive performance compared with other models (all < 0.05). SHAP analysis identified key predictive features contributing to model performance.
[CONCLUSION] The MD DL model integrating multiphasic CT and clinical parameters demonstrated high predictive accuracy for early recurrence of HCC after liver transplantation, with diagnostic performance exceeding that of conventional models.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Flap perfusion assessment with indocyanine green angiography in deep inferior epigastric perforator flap breast reconstruction: A systematic review and meta-analysis.
- A case of pulmonary mucosa-associated lymphoid tissue lymphoma with plasmacytic differentiation and amyloid deposition: case report and literature review.
- Role of ferroptosis and autophagy in pulmonary diseases.
- NUP62 Elevates USP10 Expression and Promotes Tamoxifen Resistance of Breast Cancer by Deubiquitinating ERα.
- Multi-omics analysis identifies a glycosyltransferase-related prognostic signature linked to the immune landscape in colorectal cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- LCMS-Net: Deep Learning for Raw High Resolution Mass Spectrometry Data Applied to Forensic Cause-of-Death Screening.
- Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma.
- Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.
- Crosstalk Between -Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.